Skip to main navigation Skip to search Skip to main content

Breast cancer patients with very high tumor HER2 expression levels might not benefit from treatment with trastzumab plus chemotherapy: A retrospective exploratory analysis of the FinHer trial

    Activity: Talk or presentation › Conference presentation

    Description

    Contributors: Joensuu H, Sperinde J, Leinonen M, Huang W, Weidler J, Bono P, isola J, Kellokumpu-Lehtinen P, Bates M,
    Period9 Dec 2009
    Event titleBreast Cancer Symposium 9-13.12.2009
    Event typeOther
    Degree of RecognitionInternational